Clinical Study of Seldiflexe (Sildenafil 12.5 mg Oral Gel Sachet in Yemeni Honey) in Patients with Erectile Dysfunction
Abstract
Introduction: Erectile dysfunction (ED) is a prevalent disorder affecting millions of men worldwide, with significant implications on quality of life and psychological well-being. The aim of this study was to evaluate the efficacy, safety, and tolerability of Seldiflexe, a novel oral gel sachet formulation of sildenafil citrate (12.5 mg in 5 g Yemeni honey), in comparison with standard sildenafil tablets (25 mg).
Methods: A randomized, double-blind, controlled trial was conducted on 80 male patients diagnosed with erectile dysfunction (ED). Patients were allocated to two groups: Seldiflexe sachet (n=40) or standard sildenafil tablet (n=40) for 4 weeks. Primary endpoints included improvement in the International Index of Erectile Function (IIEF) scores, onset of action, and adverse event profile. Results: demonstrated that Seldiflexe produced a significantly faster onset of action (mean 30 ± 5 min vs 50 ± 8 min, p<0.01) and improved tolerability, while maintaining comparable efficacy to standard tablets. This study suggests that Seldiflexe is a safe, effective, and patient-friendly alternative for the treatment of ED.
Conclusion: Seldiflexe (sildenafil 12.5 mg in Yemeni honey oral gel sachet) is a safe, effective, and well-tolerated alternative to conventional sildenafil 12.5 mg tablets for ED treatment. Its faster onset and better patient acceptability make it a promising innovation in sexual medicine.
Key words: Seldiflexe, Yemeni, Honey, Oral, Gel, Seldinafil
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 80 participants or records.
Read the paper
Related studies
- 2024 update in heart failure
- Vascular involvement in idiopathic pulmonary fibrosis
- A novel technique- subendometrial autologous platelet rich plasma injection in patients with unresponsive thin endometrium undergoing frozen-thawed embryo transfer: a prospective cohort study
- Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial
- Combined Pulmonary Fibrosis and Emphysema (CPFE): A "New" Smoking-Related Interstitial Lung Disease (ILD)
- Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.